Adverse events associated with childhood vaccines evidence bearing on causality

Detalles Bibliográficos
Autores Corporativos: Institute of Medicine (U.S.). Vaccine Safety Committee (-), National Institute of Allergy and Infectious Diseases (U.S.)
Otros Autores: Stratton, Kathleen R. (-), Howe, Cynthia J., Johnston, Richard B., 1935-
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academy Press 1994.
Edición:1st ed
Materias:
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820335406719
Tabla de Contenidos:
  • Adverse Events Associated with CHILDHOOD VACCINES
  • Copyright
  • Preface
  • Acknowledgments
  • Contents
  • 1 Executive Summary
  • BACKGROUND AND HISTORY
  • THE CHARGE TO THE COMMITTEE
  • THE STUDY PROCESS
  • CAUSALITY AND WEIGHT OF EVIDENCE
  • NEED FOR RESEARCH AND SURVEILLANCE
  • REFERENCES
  • 2 Causality and Evidence
  • CAUSALITY
  • Definitions
  • Types of Causal Questions
  • Can It?
  • Did It?
  • Will It?
  • SOURCES OF EVIDENCE FOR CAUSALITY
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Combining the Evidence
  • SUMMARIZING THE EVIDENCE FOR CAUSALITY
  • REFERENCES
  • 3 Neurologic Disorders
  • DEMYELINATING DISEASE
  • Experimental Models
  • Acute Disseminated Encephalomyelitis
  • Multiple Sclerosis
  • Focal Lesions
  • Guillain-Barré Syndrome
  • Historical Background
  • Clinical and Laboratory Features
  • Diagnostic Criteria
  • Antecedent Events
  • Pathology and Pathogenesis
  • Descriptive Epidemiology
  • Summary of Demyelinating Diseases
  • NON-DEMYELINATING DISEASE
  • Encephalopathy
  • Subacute Sclerosing Panencephalitis
  • Clinical and Laboratory Features
  • Pathology and Pathogenesis
  • Descriptive Epidemiology
  • Residual Seizure Disorder
  • Sensorineural Deafness
  • Neuropathy
  • Mononeuropathy
  • Brachial Neuritis
  • REFERENCES
  • 4 Immunologic Reactions
  • ANAPHYLAXIS
  • INTERACTION OF ANTIBODY WITH NORMAL TISSUE ANTIGENS
  • ARTHUS REACTION
  • DELAYED-TYPE HYPERSENSITIVITY
  • EFFECT OF VACCINES ON THE IMMUNE SYSTEM
  • REFERENCES
  • 5 Diphtheria and Tetanus Toxoids
  • BACKGROUND AND HISTORY
  • Tetanus
  • Diphtheria
  • BIOLOGIC EVENTS FOLLOWING IMMUNIZATION
  • Tetanus
  • Diphtheria
  • ENCEPHALOPATHY
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility.
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • RESIDUAL SEIZURE DISORDER
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • DEMYELINATING DISEASES OF THE CENTRAL NERVOUS SYSTEM
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series. and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • GUILLAIN-BARRÉ SYNDROME
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • Risk-Modifying Factors
  • NEUROPATHY
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • Risk-Modifying Factors
  • ARTHRITIS
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • ERYTHEMA MULTIFORME
  • Clinical Description
  • History of Suspected Association.
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • ANAPHYLAXIS
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • Risk-Modifying Factors
  • DEATH
  • Causality Argument
  • Conclusion
  • REFERENCES
  • 6 Measles and Mumps Vaccines
  • BACKGROUND AND HISTORY
  • Measles
  • Mumps
  • BIOLOGIC EVENTS FOLLOWING IMMUNIZATION
  • Measles
  • Mumps
  • ENCEPHALOPATHY AND ENCEPHALITIS
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • ASEPTIC MENINGITIS
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • SUBACUTE SCLEROSING PANENCEPHALITIS
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • RESIDUAL SEIZURE DISORDER
  • Clinical Description
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies.
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • SENSORINEURAL DEAFNESS
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • OPTIC NEURITIS
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • TRANSVERSE MYELITIS
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Studies, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • GUILLAIN-BARRÉ SYNDROME
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • INSULIN-DEPENDENT DIABETES MELLITUS
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • STERILITY DUE TO ORCHITIS
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies.
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • THROMBOCYTOPENIA
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • Risk-Modifying Factors
  • ANAPHYLAXIS
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • Risk-Modifying Factors
  • DEATH
  • Causality Argument
  • Conclusion
  • REFERENCES
  • 7 Polio Vaccines
  • BACKGROUND AND HISTORY
  • BIOLOGIC EVENTS FOLLOWING IMMUNIZATION
  • POLIOMYELITIS
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • Risk-Modifying Factors
  • TRANSVERSE MYELITIS
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • GUILLAIN-BARRÉ SYNDROME
  • Clinical Description
  • History of Suspected Association
  • Evidence for Association
  • Biologic Plausibility
  • Case Reports, Case Series, and Uncontrolled Observational Studies
  • Controlled Observational Studies
  • Controlled Clinical Trials
  • Causality Argument
  • Conclusion
  • Risk-Modifying Factors.
  • ANAPHYLAXIS AND THROMBOCYTOPENIA.